Toikumo, Sylvanus
Vickers-Smith, Rachel
Jinwala, Zeal http://orcid.org/0009-0005-5062-0827
Xu, Heng
Saini, Divya
Hartwell, Emily E. http://orcid.org/0000-0002-5137-9714
Pavicic, Mirko http://orcid.org/0000-0002-2908-3183
Sullivan, Kyle A. http://orcid.org/0000-0002-4621-5598
Xu, Ke http://orcid.org/0000-0002-6472-7052
Jacobson, Daniel A. http://orcid.org/0000-0002-9822-8251
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Rentsch, Christopher T. http://orcid.org/0000-0002-1408-7907
Pavicic, Mirko
Stahl, Eli
Cheatle, Martin
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Waxman, Stephen G. http://orcid.org/0000-0001-5718-7177
Justice, Amy C.
Kember, Rachel L. http://orcid.org/0000-0001-8820-2659
Kranzler, Henry R. http://orcid.org/0000-0002-1018-0450
,
Funding for this research was provided by:
U.S. Department of Veterans Affairs (I01 BX003341, IK2 CX002336, I01 BX003341)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (K01 AA028292)
Article History
Received: 8 March 2023
Accepted: 27 January 2024
First Online: 1 March 2024
Change Date: 7 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-03024-4
Competing interests
: H.R.K. is a member of advisory boards for Dicerna Pharmaceuticals, Sophrosyne Pharmaceuticals, Enthion Pharmaceuticals and Clearmind Medicine; a consultant to Sobrera Pharmaceuticals; the recipient of research funding and medication supplies from Alkermes for an investigator-initiated study; and a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported in the last 3 years by Alkermes, Dicerna, Ethypharm, Lundbeck, Mitsubishi and Otsuka. H.R.K. and J.G. are named as inventors on PCT patent application 15/878,640 entitled ‘genotype-guided dosing of opioid agonists’, filed on 24 January 2018. E.S. is a full-time employee of Regeneron Pharmaceuticals. The other authors declare no competing interests.